2,043 research outputs found

    Patient-Specific Effects of Medication Using Latent Force Models with Gaussian Processes

    Full text link
    Multi-output Gaussian processes (GPs) are a flexible Bayesian nonparametric framework that has proven useful in jointly modeling the physiological states of patients in medical time series data. However, capturing the short-term effects of drugs and therapeutic interventions on patient physiological state remains challenging. We propose a novel approach that models the effect of interventions as a hybrid Gaussian process composed of a GP capturing patient physiology convolved with a latent force model capturing effects of treatments on specific physiological features. This convolution of a multi-output GP with a GP including a causal time-marked kernel leads to a well-characterized model of the patients' physiological state responding to interventions. We show that our model leads to analytically tractable cross-covariance functions, allowing scalable inference. Our hierarchical model includes estimates of patient-specific effects but allows sharing of support across patients. Our approach achieves competitive predictive performance on challenging hospital data, where we recover patient-specific response to the administration of three common drugs: one antihypertensive drug and two anticoagulants

    Home detection of freezing of gait using Support Vector Machines through a single waist-worn triaxial accelerometer

    Get PDF
    Among Parkinson’s disease (PD) symptoms, freezing of gait (FoG) is one of the most debilitating. To assess FoG, current clinical practice mostly employs repeated evaluations over weeks and months based on questionnaires, which may not accurately map the severity of this symptom. The use of a non-invasive system to monitor the activities of daily living (ADL) and the PD symptoms experienced by patients throughout the day could provide a more accurate and objective evaluation of FoG in order to better understand the evolution of the disease and allow for a more informed decision-making process in making adjustments to the patient’s treatment plan. This paper presents a new algorithm to detect FoG with a machine learning approach based on Support Vector Machines (SVM) and a single tri-axial accelerometer worn at the waist. The method is evaluated through the acceleration signals in an outpatient setting gathered from 21 PD patients at their home and evaluated under two different conditions: first, a generic model is tested by using a leave-one-out approach and, second, a personalised model that also uses part of the dataset from each patient. Results show a significant improvement in the accuracy of the personalised model compared to the generic model, showing enhancement in the specificity and sensitivity geometric mean (GM) of 7.2%. Furthermore, the SVM approach adopted has been compared to the most comprehensive FoG detection method currently in use (referred to as MBFA in this paper). Results of our novel generic method provide an enhancement of 11.2% in the GM compared to the MBFA generic model and, in the case of the personalised model, a 10% of improvement with respect to the MBFA personalised model. Thus, our results show that a machine learning approach can be used to monitor FoG during the daily life of PD patients and, furthermore, personalised models for FoG detection can be used to improve monitoring accuracy.Peer ReviewedPostprint (published version

    Deep learning for electronic health records: risk prediction, explainability, and uncertainty

    Get PDF
    Background: Risk models are essential for care planning and disease prevention. The unsatisfactory performance of the established clinical models has raised broad awareness and concerns. An accurate, explainable, and reliable risk model is highly beneficial but remains a challenge. Objective: This thesis aims to develop deep learning models that can make more accurate risk predictions with the provision of uncertainty estimation and the ability to provide medical explanations using a large and representative electronic health records (EHR) dataset. Methods: We investigated three directions in this thesis: risk prediction, explainability, and uncertainty estimation. For risk prediction, we investigated deep learning tools that can incorporate the minimal processed EHR for modelling and comprehensively compared them with the established machine learning and clinical models. Additionally, the post-hoc explanations were applied to deep learning models for medical information retrieval, and we specifically looked into explanations in risk association and counterfactual reasoning. Uncertainty estimation was qualitatively investigated using probabilistic modelling techniques. Our analyses relied on Clinical Practice Research Datalink, which contains anonymised EHR collected from primary care, secondary care, and death registration and is representative of the UK population. Results: We introduced a deep learning model, named BEHRT, that can incorporate minimal processed EHR for risk prediction. Without expert engagement, it learned meaningful representations that can automatically cluster highly correlated diseases. Compared to the established machine learning and clinical models that relied on expert- selected predictors, our proposed deep learning model showed superior performance on a wide range of risk prediction tasks and highlighted the necessity of recalibration when applying a risk model to a population with severe prior distribution shifts, and the importance of regular model updating to preserve the model’s discrimination performance under temporal data shifts. Additionally, we showed that the deep learning model explanation is an excellent tool for discovering risk factors. By explaining the deep learning model, we not only identified factors that were highly consistent with the established evidence but also those that have not been considered in expert-driven studies. Furthermore, the deep learning model also captured the interplay between risk and treated risk and the differential association of medications across different years, which would be difficult if the temporal context was not included in the modelling. Besides the explanations in terms of association, we introduced a framework that can achieve accurate risk prediction, while enabling counterfactual reasoning under hypothetical interventions. This offers counterfactual explanations that could inform clinicians for selection of those who will benefit the most. We demonstrated the benefit of the proposed framework using two exemplary case studies. Furthermore, transforming a deterministic deep learning model to probabilistic can make predictions with an uncertainty range. We showed that such information has many potential implications in practice, such as quantifying the confidence of a decision, indicating data insufficiency, distinguishing the correct and incorrect predictions, and indicating risk associations. Conclusions: Deep learning models led to substantially improved performance for risk prediction. The ability of uncertainty estimation can quantify the confidence of risk prediction to further inform clinical decision-making. Deep learning model explanation can generate hypotheses to guide medical research and provide counterfactual analysis to assist clinical decision-making. This encouraging evidence supports the great potential of incorporating deep learning methods into electronic health records to inform a wide range of health applications such as care planning, disease prevention, and medical study design

    Studies on using data-driven decision support systems to improve personalized medicine processes

    Full text link
    This dissertation looks at how new sources of information should be incorporated into medical decision-making processes to improve patient outcomes and reduce costs. There are three fundamental challenges that must be overcome to effectively use personalized medicine, we need to understand: 1) how best to appropriately designate which patients will receive the greatest value from these processes; 2) how physicians and caregivers interpret additional patient-specific information and how that affects their decision-making processes; and finally, (3) how to account for a patient’s ability to engage in their own healthcare decisions. The first study looks at how we can infer which patients will receive the most value from genomic testing. The difficult statistical problem is how to separate the distribution of patients, based on ex-ante factors, to identify the best candidates for personalized testing. A model was constructed to infer a healthcare provider’s decision on whether this test would provide beneficial information in selecting a patient’s medication. Model analysis shows that healthcare providers’ primary focus is to maximize patient health outcomes while considering the impact the patient’s economic welfare. The second study focuses on understanding how technology-enabled continuity of care (TECC) for Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) patients can be utilized to improve patient engagement, measured in terms of patient activation. We shed light on the fact that different types of patients garnered different levels of value from the use of TECC. The third study looks at how data-driven decision support systems can allow physicians to more accurately understand which patients are at high-risk of readmission. We look at how we can use available patient-specific information for patients admitted with CHF to more accurately identify which patients are most likely to be readmitted, and also why – whether for condition-related reasons versus for non- related reasons, allowing physicians to suggest different patient-specific readmission prevention strategies. Taken together, these three studies allow us to build a robust theory to tackle these challenges, both operational and policy-related, that need to be addressed for physicians to take advantage of the growing availability of patient-specific information to improve personalized medication processes

    Visualizing and Predicting the Effects of Rheumatoid Arthritis on Hands

    Get PDF
    This dissertation was inspired by difficult decisions patients of chronic diseases have to make about about treatment options in light of uncertainty. We look at rheumatoid arthritis (RA), a chronic, autoimmune disease that primarily affects the synovial joints of the hands and causes pain and deformities. In this work, we focus on several parts of a computer-based decision tool that patients can interact with using gestures, ask questions about the disease, and visualize possible futures. We propose a hand gesture based interaction method that is easily setup in a doctor\u27s office and can be trained using a custom set of gestures that are least painful. Our system is versatile and can be used for operations like simple selections to navigating a 3D world. We propose a point distribution model (PDM) that is capable of modeling hand deformities that occur due to RA and a generalized fitting method for use on radiographs of hands. Using our shape model, we show novel visualization of disease progression. Using expertly staged radiographs, we propose a novel distance metric learning and embedding technique that can be used to automatically stage an unlabeled radiograph. Given a large set of expertly labeled radiographs, our data-driven approach can be used to extract different modes of deformation specific to a disease

    Probabilistic modelling of gait for robust passive monitoring in daily life

    Get PDF
    Passive monitoring in daily life may provide valuable insights into a person's health throughout the day. Wearable sensor devices play a key role in enabling such monitoring in a non-obtrusive fashion. However, sensor data collected in daily life reflect multiple health and behavior-related factors together. This creates the need for a structured principled analysis to produce reliable and interpretable predictions that can be used to support clinical diagnosis and treatment. In this work we develop a principled modelling approach for free-living gait (walking) analysis. Gait is a promising target for non-obtrusive monitoring because it is common and indicative of many different movement disorders such as Parkinson's disease (PD), yet its analysis has largely been limited to experimentally controlled lab settings. To locate and characterize stationary gait segments in free-living using accelerometers, we present an unsupervised probabilistic framework designed to segment signals into differing gait and non-gait patterns. We evaluate the approach using a new video-referenced dataset including 25 PD patients with motor fluctuations and 25 age-matched controls, performing unscripted daily living activities in and around their own houses. Using this dataset, we demonstrate the framework's ability to detect gait and predict medication induced fluctuations in PD patients based on free-living gait. We show that our approach is robust to varying sensor locations, including the wrist, ankle, trouser pocket and lower back
    • …
    corecore